budesonide
Budesonide is nebulized for maintenance and prophylactic treatment of asthma including patients who require oral corticosteroids and those who may benefit from a systemic dose reduction. It was initially patented in 1973. It sold under the brand name Pulmicort among others, is a medication of the corticosteroid type.. Reference standards of Budesonide API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object
(
[pname] => Budesonide (B1157300)
[catalogue_number] => PA EPB1157300
[category_ids] => ,150,
[chemical_name] =>
[weight] => NA
[form] => NA
[cas] => NA
[pslug] => budesonide-b1157300-paepb1157300
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
stdClass Object
(
[pname] => Budesonide for system suitability (Y0001148)
[catalogue_number] => PA EPY0001148
[category_ids] => ,150,
[chemical_name] =>
[weight] => NA
[form] => NA
[cas] => NA
[pslug] => budesonide-for-system-suitability-y0001148-paepy0001148
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Budesonide for system suitability (Y0001148)
